Get started
Author

Yves Mucyo Habimana

Observed names: Habimana, Yves Mucyo, Y. HABIMANA, Y. Habimana, Y. M. Habimana, Y. Mucyo, Y.M. Habimana, Yves Habimana Mucyo, Yves Habimana-Mucyo, Yves M Habimana, Yves M. Habimana, Yves Mucyo, Yves Mucyo-Habimana
Observed institution: Rwanda Biomedical Center
ORCID: 0000-0001-6097-1405
Observed ORCID: 0000-0001-6097-1405
OpenAlex ID: A5069490240
A sister lineage of the Mycobacterium tuberculosis complex discovered in the African Great Lakes region
2020 · Jean Claude Semuto Ngabonziza, Chloé Loiseau, et al. · Nature Communications · 230
PDF
Prevalence and drivers of false-positive rifampicin-resistant Xpert MTB/RIF results: a prospective observational study in Rwanda
2020 · Jean Claude Semuto Ngabonziza, Tom Decroo, et al. · The Lancet Microbe · 65
PDF
Reduction of diagnostic and treatment delays reduces rifampicin-resistant tuberculosis mortality in Rwanda
2020 · J-C. S. Ngabonziza, Y. M. Habimana, et al. · The International Journal of Tuberculosis and Lung Disease · 43
Combatting Substandard and Falsified Medicines: A View from Rwanda
2013 · Agnes Binagwaho, Roger Bate, et al. · PLoS Medicine · 37
PDF
Paucibacillary Tuberculosis Drives the Low Positive Predictive Value of Xpert MTB/RIF Ultra for Rifampicin Resistance Detection in Low-Prevalence Settings
2025 · Isabel Cuella-Martin, Francois Hakizayezu, et al. · Clinical Infectious Diseases · 16
Multidrug-resistant tuberculosis control in Rwanda overcomes a successful clone that causes most disease over a quarter century
2022 · Jean Claude S. Ngabonziza, Leen Rigouts, et al. · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · 12
PDF
Predictors of Rifampicin-Resistant Tuberculosis Mortality among HIV-Coinfected Patients in Rwanda
2021 · Dominique Savio Habimana, Jean Claude Semuto Ngabonziza, et al. · American Journal of Tropical Medicine and Hygiene · 11
PDF
Low Cycle Threshold Value in Xpert MTB/RIF Assay May Herald False Detection of Tuberculosis and Rifampicin Resistance: A Study of Two Cases
2021 · Jean Claude S Ngabonziza, Tom Decroo, et al. · Open Forum Infectious Diseases · 8
PDF
Continuous surveillance of drug-resistant TB burden in Rwanda: a retrospective cross-sectional study
2022 · Yves Habimana-Mucyo, Augustin Dushime, et al. · International Health · 7
PDF
Case Report: Dynamics of Acquired Fluoroquinolone Resistance under Standardized Short-Course Treatment of Multidrug-Resistant Tuberculosis
2020 · Jean Claude Semuto Ngabonziza, Armand Van Deun, et al. · American Journal of Tropical Medicine and Hygiene · 7
PDF
Highly successful treatment outcome of multidrug‐resistant and genetic diversity of multidrug‐resistant Mycobacterium tuberculosis strains in Rwanda
2019 · Claude Mambo Muvunyi, Jean Claude Semuto Ngabonziza, et al. · Tropical Medicine & International Health · 7
High-dose amikacin in the first week of all-oral rifampicin-resistant TB treatment is safe: a single-arm trial
2025 · J. Snobre, J. Gasana, et al. · IJTLD OPEN · 2
Epidemiology and outcomes of multidrug-resistant tuberculosis in Rwanda
2025 · J. NTWARI, R. NDIAYE, et al. · Infectious Diseases Now · 1
Safety of high-dose amikacin in the first week of all-oral rifampicin-resistant tuberculosis treatment for the prevention of acquired resistance (STAKE): protocol for a single-arm clinical trial
2024 · Jihad Snobre, Joel Gasana, et al. · BMJ Open · 1
PDF
Spatial clustering and transmission networks of multidrug-resistant tuberculosis in Rwanda: a national retrospective genomic and spatial epidemiological study
2026 · Isabel Cuella-Martin, Francois Hakizayezu, et al. · BMJ Open
Key operational challenges at a programmatic level to achieve optimal use of the GeneXpert platform
2026 · I. Cuella-Martin, F. Hakizayezu, et al. · IJTLD OPEN
Tracking cross-border transmission of Rwanda’s successful dominant rifampicin-resistant Mycobacterium tuberculosis clone using genomic markers
2026 · Isabel Cuella-Martin, Wim Mulders, et al. · medRxiv
PDF
Direct thin-layer agar for bedaquiline-susceptibility testing of Mycobacterium tuberculosis at BSL2 level yields high accuracy in 15 days from sputum processing
2025 · I. Cuella Martin, D. Runyambo, et al. · Journal of Clinical Microbiology
Caractéristiques de la tuberculose résistante au Rwanda : une analyse rétrospective nationale 2019-2023
2024 · J. Ntwari, Y. Habimana, et al. · Médecine et Maladies Infectieuses Formation
The Regional Centre Of Excellence On Programmatic Management Of DrugResistant Tuberculosis.
2013 · Yves Habimana Mucyo · TSpace (University of Toronto)
PDF
Works count: 22
Citation count: 447
H-index: 8
I10-index: 7
Year
Topic
Type